Abeona Therapeutics Announces Dismissal of Securities Class Action Lawsuit
Feb 23, 2017 12:43 pm UTC| Business
Securities Class Action Lawsuit lacked any valid basis and was voluntarily dismissed NEW YORK and CLEVELAND, Feb. 23, 2017 -- Abeona Therapeutics Inc. (Nasdaq:ABEO), a leading clinical-stage biopharmaceutical company...
EDAP Announces Preliminary Unaudited Full Year 2016 Revenue
Feb 23, 2017 12:31 pm UTC| Business
EDAP Announces Preliminary Unaudited Full Year 2016 Revenue Full year 2016 revenue increased to approximately €35.6 million 2016 HIFU revenues recorded over 63% growthStrong cash position of €22 millionCompany to...
Frank’s International N.V. Announces Fourth Quarter and Full Year 2016 Results
Feb 23, 2017 12:30 pm UTC| Business
HOUSTON, Feb. 23, 2017 -- Frank’s International N.V. (NYSE:FI) (the “Company” or “Frank’s”) today reported revenues of $108.0 million and net loss of $66.2 million, or $0.30 per share, for the three months ended...
BroadSoft Reports Fourth Quarter and Full Year 2016 Financial Results
Feb 23, 2017 12:30 pm UTC| Business
GAITHERSBURG, Md., Feb. 23, 2017 -- BroadSoft, Inc. (NASDAQ:BSFT), a global unified communication software as a service (UCaaS) leader, today announced financial results for the fourth quarter and twelve-month period...
Mandalay Resources Corporation Replaces Mineral Resources and Reserves in Year-End 2016 Update
Feb 23, 2017 12:30 pm UTC| Business
TORONTO, Feb. 23, 2017 -- Mandalay Resources Corporation ("Mandalay" or the "Company") (TSX:MND) today announced its year-end 2016 Mineral Resources and Reserves estimations. In the Proven and Probable Reserves category...
JA Solar Announces Preliminary 2016 Financial Results
Feb 23, 2017 12:30 pm UTC| Business
BEIJING, Feb. 23, 2017 -- JA Solar Holdings Co., Ltd. (Nasdaq:JASO) ("JA Solar" or the "Company"), one of the world's largest manufacturers of high-performance solar power products, today announced preliminary estimates...
KemPharm Announces Additional Patent Protection for Prodrug Portfolio
Feb 23, 2017 12:30 pm UTC| Business
US Patent and Trademark Office decision extends additional patent protection to KP201 and the KP511 compound family CORALVILLE, Iowa, Feb. 23, 2017 -- KemPharm, Inc. (NASDAQ:KMPH), a clinical-stage specialty...